By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
IBM's Q2 results and subsequent 25% drop reflect slowing software growth and hardware declines, with long-term bets on quantum and foundry output not yet translating into revenue. The panel is bearish on IBM's prospects due to structural shifts in enterprise IT spending, slowing software momentum, and execution risks around quantum and foundry initiatives.
Risk: Slowing software growth and execution risks around quantum and foundry initiatives
Opportunity: Red Hat's 11% growth and potential benefits from CHIPS Act foundry funding
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
International Business Machines (NYSE: IBM) just experienced one of the largest one-day declines in its history. That 25% drop on Tuesday came after CEO Arvind Krishna admitted that high capital expenditures on hardware had caused many companies to shift budgets away from software spending.
Such a sharp reaction from the market will understandably leave many investors wondering how to react. However, there are good reasons to treat this plunge as a buying opportunity.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Admittedly, the negative reaction to Krishna's statement was understandable. According to IBM's preliminary Q2 results, the company's revenue grew by just 1% year over year. That is well below its 9% increase in Q1 and brought revenue growth down to levels comparable to where IBM was before Krishna shifted the company's focus to the cloud and AI.
Software is now IBM's largest business segment, accounting for almost 45% of the company's revenue in the first quarter. Additionally, the software segment's annual growth rate fell from 11% in Q1 to just 5% in Q2.
Moreover, while IBM still operates an enterprise hardware business, its infrastructure segment experienced a 7% annual revenue decline in Q2. Hence, it does not appear to have benefited from the boom in hardware spending.
Nonetheless, the one benefit to investors is that the drop in this tech stock seems to have instantaneously priced in this particular challenge. IBM's P/E ratio is now just 19, near its multiyear low. As recently as last fall, its earnings multiple was above 40, so this pullback represents a considerable discount.
Moreover, under Krishna's leadership, IBM's total returns have outpaced the S&P 500, indicating that he has earned investors' confidence during his six-year tenure as the head of the company.
Also, not all of the news in the preliminary report was negative. Red Hat's year-over-year revenue growth in Q2 was 11%, indicating that bright spots remain in IBM's software business.
Furthermore, the U.S. government is betting billions on quantum computing, and IBM has long led the way in that technology. Amid its partnership with the government, IBM in May announced plans for the construction of Anderon, the first pure-play foundry to build quantum wafers.
In addition to the $2 billion investment in the foundry ($1 billion of which came from CHIPS Act funds), it plans to invest $10 billion in quantum technology over the next five years. Such investments greatly increase the odds that IBM will be a major player in a technology that's likely to drive innovation for years to come.
The struggles in the software sector and IBM's 1% revenue growth in Q2 are likely to continue weighing on the stock in the near term.
Fortunately, despite the sell-off, IBM stock has prospered under Krishna, and it appears that it is on track to continue outperforming in the longer term.
Additionally, the continued success of Red Hat and its investments in quantum computing should serve IBM well in the coming years. With this growth story now on sale at just 19 times earnings, Tuesday's stock price plunge could be a blessing in disguise for new investors.
Before you buy stock in International Business Machines, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and International Business Machines wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $398,160! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,249,202!
Now, it’s worth noting Stock Advisor’s total average return is 918% — a market-crushing outperformance compared to 209% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of July 15, 2026. *
Will Healy has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends International Business Machines. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"IBM's software slowdown is real and likely persistent, making the post-plunge 19x P/E look fair rather than compelling."
IBM's preliminary Q2 showing 1% YoY revenue growth (down from 9% in Q1) and software growth halving to 5% validates Krishna's hardware-capex warning and explains the 25% plunge. At 19x forward P/E versus historical 25-40x, the multiple looks cheap relative to Red Hat's 11% growth and $10B quantum bet. Yet the article glosses over persistent infrastructure declines (-7%), slowing hybrid cloud momentum, and AI software competition from pure-plays. Total returns under Krishna have beaten the S&P 500 mainly via dividends; EPS growth has been mid-single digit. Valuation de-rating may have further to run if software spending stays constrained into 2026.
The strongest case against buying is that 19x P/E is not cheap if software growth settles at 4-6% and quantum remains a 2030+ revenue driver; IBM could easily re-rate to 15x or lower, erasing the 'bargain' narrative.
"IBM's revenue stagnation confirms it is losing the battle for AI-driven software budgets to more agile cloud-native competitors, making the current P/E multiple a value trap rather than a discount."
The market reaction to IBM's Q2 results is a classic case of 'growth-at-any-cost' fatigue colliding with a structural shift in enterprise IT spending. While the article highlights a 19x P/E as a value play, it ignores that IBM’s 1% revenue growth is anemic compared to peers who are successfully capturing AI-driven cloud demand. The pivot to quantum is a long-term moonshot that does little to address the immediate margin compression caused by hardware-heavy budgets. I suspect the 25% drop isn't just a reaction to one quarter, but a repricing of IBM as a legacy services firm rather than a high-growth AI player. Investors are paying for a turnaround that keeps getting pushed further out.
If IBM’s pivot to quantum computing and its Red Hat integration reach a critical mass in enterprise adoption, the current 19x multiple will look like an extreme undervaluation relative to its long-term moat.
"IBM's software deceleration from 11% to 5% YoY is more likely a demand signal than a temporary budget squeeze, and the article provides no evidence that the squeeze is reversing."
The article conflates a cyclical software spending squeeze with a secular thesis failure, then uses a 25% drawdown to argue for a bargain entry. But IBM's 1% revenue growth and software segment deceleration (11% to 5% YoY) signal demand destruction, not temporary budget reallocation. The P/E compression to 19x looks cheap until you realize it reflects lower growth expectations. Red Hat's 11% growth is a bright spot, but it's one segment. Quantum computing ($10B over five years) is speculative and multi-year out. Krishna's outperformance of the S&P 500 is real but doesn't immunize against a structural shift in enterprise IT spending priorities.
If enterprise capex cycles are genuinely rotating from hardware back to software optimization in H2 2024, IBM's software segment could re-accelerate sharply, and 19x forward earnings on normalized growth (8-10%) would be a steal.
"IBM's ~19x earnings multiple rests on uncertain monetization of its AI and quantum bets, making further multiple compression a real risk if growth falters."
IBM's 25% plunge follows a Q2 where revenue grew 1%, with software at ~45% of sales but only mid-single-digit growth; hardware declined 7%. The bear case is that this is not a temporary hiccup: software momentum is slowing, capital expenditure is structurally shifting budgets, and AI/quantum bets remain long-horizon bets with uncertain monetization. The upside hinges on Red Hat, quantum/Anderon, and a multiple re-rating, but a 19x P/E could still compress if margins stay under pressure or growth stalls. The article glosses over free cash flow durability, debt, and whether the foundry/CHIPS funding translates into durable revenue.
The selloff may reflect more persistent demand weakness for IBM's software and a longer path to monetize AI/quantum bets; the expected re-rating assumes a quick turnaround that isn't guaranteed.
"CHIPS-related foundry upside by 2026 is the overlooked offset to software deceleration nobody quantified."
Gemini's 'legacy services firm' label overlooks that IBM's $10B quantum investment and Red Hat's 11% growth already embed hybrid-cloud optionality peers lack. The real unmentioned risk: if CHIPS Act foundry funding scales wafer output by 2026, it could drive 3-5% incremental hardware revenue IBM hasn't guided for, muting the software slowdown narrative.
"IBM's reliance on hardware foundry scaling to offset software deceleration ignores the prohibitive capital intensity and margin pressure inherent in that business model."
Grok, your CHIPS Act foundry thesis is a red herring. Foundry output requires massive, margin-dilutive capex that IBM historically struggles to monetize efficiently. While others debate software growth, the real elephant is the pension liability and debt service costs, which consume the very free cash flow needed to fund these 'moonshots.' If software growth continues to decelerate, IBM cannot rely on hardware manufacturing to bridge the margin gap without further eroding shareholder returns.
"IBM's cash flow problem isn't absolute scarcity but allocation risk across too many simultaneous bets with uncertain payoff timelines."
Gemini's pension/debt argument is material but incomplete. IBM's free cash flow (~$9B annually) covers both pension obligations and debt service comfortably; the real constraint is capex intensity for quantum/foundry. Grok's CHIPS thesis conflates government funding with profitable revenue—wafer output doesn't equal margin-accretive sales. The unasked question: does IBM have the operational discipline to execute *either* quantum *or* foundry profitably, or does simultaneous pursuit dilute returns on both?
"Execution/capital-allocation risk from dual moonshots could trigger dilution or higher leverage and cap upside if monetization stalls."
Gemini, the real flaw is not just debt or pension costs but the execution risk of dual moonshots. Even with Red Hat and CHIPS/foundry subsidies, IBM faces long sales cycles and margin pressure if hardware demand remains weak. If cash flow softens, the company may need equity raises or higher leverage, crushing the multiple. Optionality only pays off if quantum and foundry monetize quickly; absent that, the 19x base case could re-rate lower.
IBM's Q2 results and subsequent 25% drop reflect slowing software growth and hardware declines, with long-term bets on quantum and foundry output not yet translating into revenue. The panel is bearish on IBM's prospects due to structural shifts in enterprise IT spending, slowing software momentum, and execution risks around quantum and foundry initiatives.
Red Hat's 11% growth and potential benefits from CHIPS Act foundry funding
Slowing software growth and execution risks around quantum and foundry initiatives